|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||
|
|
||||||||
|
|
|
|
||||||
BREAST CARCINOMA IN-SITU AND HIGH RISK PATIENTS There are two types non-invasive breast cancers recognised on the basis of histological pattern; ductal carcinoma in-situ (DCIS) and lobular carcinoma in-situ (LCIS). DCIS is the commoner form and makes up to 5% of symptomatic and 18% of screen detected cancers. In contrast, LCIS constitutes only 0.5% of symptomatic and approximately 1% of screen detected cancers. Please choose from the following: Ductal
carcinoma in situ - Lobular
carcinoma in situ - High
risk patients If
you require further advice or information please contact the |
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|